Phosphate homeostasis in CKD: Report of a scientific symposium sponsored by the national kidney foundation

American Journal of Kidney Diseases

Volumn 62, Issue 3, 2013, Pages 457-473

  Block, Geoffrey A ^a   Ix, Joachim H ^b   Ketteler, Markus ^c   Martin, Kevin J ^d   Thadhani, Ravi I ^e   Tonelli, Marcello ^f   Wolf, Myles ^g   Jüppner, Harald ^e   Hruska, Keith ^h   Wheeler, David C ⁱ  

^a Denver Nephrologists   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KLINIKUM COBURG   (Germany)

^d SAINT LOUIS UNIVERSITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

chronic kidney disease; chronic kidney disease mineral and bone disorder (CKD MBD); diet; food labeling; Phosphate

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT;

ARTICLE; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; HUMAN; HYPOPHOSPHATEMIA; KIDNEY FAILURE; NON PROFIT ORGANIZATION; NONHUMAN; NUTRITIONAL ASSESSMENT; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PHOSPHATE METABOLISM; PHOSPHATE URINE LEVEL; REGULATORY MECHANISM; URINARY EXCRETION;

CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD); DIET; FOOD LABELING; PHOSPHATE;

CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; FOUNDATIONS; HOMEOSTASIS; HUMANS; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC; RESEARCH REPORT;

EID: 84883243996     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.03.042     Document Type: Article

References (102)

1. T. Isakova, P. Wahl, G.S. Vargas Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease Kidney Int 79 12 2011 1370 1378
2. A. Levin, G.L. Bakris, M. Molitch Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int 71 1 2007 31 38
3. S.M. Moe, T.B. Drueke, G.A. Block KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int Suppl 113 2009 1 140
4. E. Slatopolsky, S. Caglar, J.P. Pennell On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog J Clin Invest 50 3 1971 492 499
5. E. Slatopolsky The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder Kidney Int 121 2011 S3 S8
6. O. Gutierrez, T. Isakova, E. Rhee Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitrol deficiency in chronic kidney disease J Am Soc Nephrol 16 2005 1 11
7. P. Evenepoel, B. Meijers, L. Viaene Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism Clin J Am Soc Nephrol 5 7 2010 1268 1276
8. C. Bergwitz, H. Juppner Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23 Annu Rev Med 61 2010 91 104
9. O.M. Gutierrez Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis Clin J Am Soc Nephrol 5 9 2010 1710 1716
10. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin, F.K. Port Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 4 1998 607 617
11. G.A. Block, P.S. Klassen, J.M. Lazarus, N. Ofsthun, E.G. Lowrie, G.M. Chertow Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 8 2004 2208 2218
12. M. Abramowitz, P. Muntner, M. Coco Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization Clin J Am Soc Nephrol 5 6 2010 1064 1071
13. K.L. Adeney, D.S. Siscovick, J.H. Ix Association of serum phosphate with vascular and valvular calcification in moderate CKD J Am Soc Nephrol 20 2 2009 381 387
14. C. Zoccali, P. Ruggenenti, A. Perna Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition J Am Soc Nephrol 22 10 2011 1923 1930
15. R. Dhingra, L.M. Sullivan, C.S. Fox Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community Arch Intern Med 167 9 2007 879 885
16. R. Dhingra, P. Gona, E.J. Benjamin Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community Eur J Heart Fail 12 8 2010 812 818
17. C.M. O'Seaghdha, S.J. Hwang, P. Muntner, M.L. Melamed, C.S. Fox Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease Nephrol Dial Transplant 26 9 2011 2885 2890
18. R.N. Foley Phosphate levels and cardiovascular disease in the general population Clin J Am Soc Nephrol 2009 http://dx.doi.org/10.2215/CJN.01660309 Accessed May 7, 2012
19. M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, G. Curhan Relation between serum phosphate level and cardiovascular event rate in people with coronary disease Circulation 112 17 2005 2627 2633
20. J. Uribarri Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake Semin Dial 20 4 2007 295 301
21. J. Uribarri, M.S. Calvo Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial 16 3 2003 186 188
22. National Institute of Health and Clinical Excellence Chronic Kidney Disease: Early Identification and Managment of Chronic Kidney Disease in Adults in Primary and Secondary Care CG73 2008 National Institute for Health and Clinical Excellence London, UK
23. B. Kestenbaum, J.N. Sampson, K.D. Rudser Serum phosphate levels and mortality risk among people with chronic kidney disease J Am Soc Nephrol 16 2 2005 520 528
24. G.J. Becker, R.G. Walker, T.D. Hewitson, E. Pedagogos Phosphate levels - time for a rethink? Nephrol Dial Transplant 24 8 2009 2321 2324
25. A.A. Portale, B.P. Halloran, R.C. Morris Jr Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus Implications for the renal production of 1,25-dihydroxyvitamin D J Clin Invest 80 4 1987 1147 1154
26. S.M. Moe, M.P. Zidehsarai, M.A. Chambers Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease Clin J Am Soc Nephrol 6 2 2011 257 264
27. I.H. de Boer, T.C. Rue, B. Kestenbaum Serum phosphorus concentrations in the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 53 3 2009 399 407
28. K. Hill, B. Martin, M. Wastney Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease Kidney Int 83 5 2013 959 966
29. L. Craver, M.P. Marco, I. Martinez Mineral metabolism parameters throughout chronic kidney disease stages 1-5 - achievement of K/DOQI target ranges Nephrol Dial Transplant 22 4 2007 1171 1176
30. J.K.B. Dominguez, M. Chonchol, G. Block Relationship between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOs) Study Am J Kidney Dis 61 4 2012 555 563
31. J.R. Dominguez, M.G. Shlipak, M.A. Whooley, J.H. Ix Fractional excretion of phosphorus modifies the association between fibroblast growth factor 23 and outcomes J Am Soc Nephrol 24 2013 1 8
32. N. Noori, K. Kalantar-Zadeh, C.P. Kovesdy, R. Bross, D. Benner, J.D. Kopple Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients Clin J Am Soc Nephrol 5 4 2010 683 692
33. C.S. Shinaberger, S. Greenland, J.D. Kopple Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88 6 2008 1511 1518
34. D.M. Antoniucci, T. Yamashita, A.A. Portale Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men J Clin Endocrinol Metab 91 8 2006 3144 3149
35. E. Gonzalez-Parra, M.L. Gonzalez-Casaus, A. Galan Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients Nephrol Dial Transplant 26 8 2011 2567 2571
36. T. Isakova, O. Gutierrez, A. Shah Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD J Am Soc Nephrol 19 3 2008 615 623
37. M. Sigrist, M. Tang, M. Beaulieu Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial Nephrol Dial Transplant 28 1 2013 161 169
38. B. Newsome, J.H. Ix, H. Tighiouart Diet modification effects on serum and urine phosphorus levels: the Modification of Diet in Renal Disease Study Am J Kidney Dis 61 6 2013 1045 1046
39. K.T. Yamamoto, C. Robinson-Cohen, M.C. de Oliveira Dietary phosphorus is associated with left ventricular mass: the Multi-Ethnic Study of Atherosclerosis Kidney Int 83 4 2013 707 714
40. J. Houston, K. Smith, T. Isakova, N. Sowden, M. Wolf, O.M. Gutierrez Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease J Ren Nutr 23 1 2013 12 20
41. O.M. Gutierrez, M. Wolf, E.N. Taylor Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the Health Professionals Follow-up Study Clin J Am Soc Nephrol 2011 10.2215/CJN.02740311
42. G.A. Block, D.C. Wheeler, M.S. Persky Effects of phosphate binders in moderate CKD J Am Soc Nephrol 23 8 2012 1407 1415
43. A.G. Bostom New evidence for the phosphorus-lowering effects of niacin Am J Kidney Dis 56 1 2010 185
44. Y. Sabbagh, S.P. O'Brien, W. Song Intestinal npt2b plays a major role in phosphate absorption and homeostasis J Am Soc Nephrol 20 11 2009 2348 2358
45. J.H. Ix, P. Ganjoo, D. Tipping, A.M. Tershakovec, A.G. Bostom Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients Am J Kidney Dis 57 6 2011 963 965
46. V. Savica, L.A. Calo, P. Monardo Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients J Am Soc Nephrol 20 3 2009 639 644
47. K. Kalantar-Zadeh, L. Gutekunst, R. Mehrotra Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease Clin J Am Soc Nephrol 5 3 2010 519 530
48. R.A. Sherman, O. Mehta Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis Clin J Am Soc Nephrol 4 8 2009 1370 1373
49. R.R. Bell, H.H. Draper, D.Y. Tzeng, H.K. Shin, G.R. Schmidt Physiological responses of human adults to foods containing phosphate additives J Nutr 107 1 1977 42 50
50. Leon JB, Sullivan CM, Sehgal AR. The prevalence of phosphorus containing food additives in top-selling foods in grocery stores [published online ahead of print February 8, 2013]. J Ren Nutr. doi: 10.1053/j.jrn2013.12.003.
51. C. Sullivan, S.S. Sayre, J.B. Leon Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial JAMA 301 6 2009 629 635
52. O.M. Gutierrez, C. Anderson, T. Isakova Low socioeconomic status associates with higher serum phosphate irrespective of race J Am Soc Nephrol 21 11 2010 1953 1960
53. K. Kalantar-Zadeh, L. Gutekunst, R. Mehrotra Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease Clin J Am Soc Nephrol 5 3 2010 519 530
54. G.R. Davis, J.E. Zerwekh, T.F. Parker, G.J. Krejs, C.Y. Pak, J.S. Fordtran Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency Gastroenterology 85 4 1983 908 916
55. B. Kestenbaum Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment Semin Dial 20 4 2007 286 294
56. M. Wolf Fibroblast growth factor 23 and the future of phosphorus management Curr Opin Nephrol Hypertens 18 6 2009 463 468
57. T. Shimada, M. Kakitani, Y. Yamazaki Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest 113 4 2004 561 568
58. T. Shimada, T. Muto, I. Urakawa Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo Endocrinology 143 8 2002 3179 3182
59. H. Juppner Phosphate and FGF-23 Kidney Int Suppl 121 2011 S24 S27
60. M. Kuro-o Overview of the FGF23-klotho axis Pediatr Nephrol 25 4 2010 583 590
61. O.M. Kuro Klotho in health and disease Curr Opin Nephrol Hypertens 21 4 2012 362 368
62. F. Perwad, A.A. Portale Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23 Mol Cell Endocrinol 347 1-2 2011 17 24
63. P. Wahl, M. Wolf FGF23 in chronic kidney disease Adv Exp Med Biol 728 2012 107 125
64. K.E. White, T.E. Larsson, M.J. Econs The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23 Endocr Rev 27 3 2006 221 241
65. T. Isakova, H. Xie, W. Yang Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease JAMA 305 23 2011 2432 2439
66. R.D. Semba, J.C. Fink, K. Sun Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women Clin J Am Soc Nephrol 7 1 2012 85 91
67. E.G. Farrow, X. Yu, L.J. Summers Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice Proc Natl Acad Sci U S A 108 46 2011 E1146 E1155
68. C. Faul, A.P. Amaral, B. Oskouei FGF23 induces left ventricular hypertrophy J Clin Invest 121 11 October 2011 4393 4408
69. M.C. Hu, M. Kuro-o, O.W. Moe The emerging role of klotho in clinical nephrology Nephrol Dial Transplant 27 7 2012 2650 2657
70. M.C. Hu, O.M. Kuro, O.W. Moe Secreted klotho and chronic kidney disease Adv Exp Med Biol 728 2012 126 157
71. H. Hasegawa, N. Nagano, I. Urakawa Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease Kidney Int 78 10 2010 975 980
72. V. Shalhoub, E.M. Shatzen, S.C. Ward FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality J Clin Invest 122 7 2012 2543 2553
73. C. Faul, A.P. Amaral, B. Oskouei FGF23 induces left ventricular hypertrophy J Clin Invest 121 11 2011 4393 4408
74. R. Marsell, T. Krajisnik, H. Goransson Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23 Nephrol Dial Transplant 23 3 2008 827 833
75. K. Lim, T.S. Lu, G. Molostvov Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23 Circulation 125 18 2012 2243 2255
76. M. Kuro-o Phosphate and klotho Kidney Int Suppl 121 2011 S20 S23
77. J. Silver, M. Rodriguez, E. Slatopolsky FGF23 and PTH - double agents at the heart of CKD Nephrol Dial Transplant 27 5 2012 1715 1720
78. V. Lavi-Moshayoff, G. Wasserman, T. Meir, J. Silver, T. Naveh-Many PTH increases FGF23 gene expression and mediates the high FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop Am J Physiol Renal Physiol 299 4 2010 F882 F889
79. M.E. Rodriguez-Ortiz, I. Lopez, J.R. Munoz-Castaneda Calcium deficiency reduces circulating levels of FGF23 J Am Soc Nephrol 23 7 2012 1190 1197
80. Q. Yuan, T. Sato, M. Densmore FGF-23/klotho signaling is not essential for the phosphaturic and anabolic functions of PTH J Bone Miner Res 26 9 2011 2026 2035
81. G. Zoppellaro, E. Faggin, M. Puato, P. Pauletto, M. Rattazzi Fibroblast growth factor 23 and the bone-vascular axis: lessons learned from animal studies Am J Kidney Dis 59 1 2012 135 144
82. Scialla J, Lau WL, Reilly MP, et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification [published online ahead of print February 6, 2013]. Kidney Int. doi: 10.1038/ki.2013.3.
83. J. Marks, E.S. Debnam, R.J. Unwin Phosphate homeostasis and the renal-gastrointestinal axis Am J Physiol Renal Physiol 299 2 2010 F285 F296
84. G. Jaureguiberry, T.O. Carpenter, S. Forman, H. Juppner, C. Bergwitz A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc Am J Physiol Renal Physiol 295 2 2008 F371 F379
85. S.C. Schiavi, W. Tang, C. Bracken Npt2b deletion attenuates hyperphosphatemia associated with CKD J Am Soc Nephrol 23 10 2012 1691 1700
86. S.M. Moe, J.S. Radcliffe, K.E. White The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat J Bone Miner Res 26 11 2011 2672 2681
87. A. Corut, A. Senyigit, S.A. Ugur Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis Am J Hum Genet 79 4 2006 650 656
88. D. Magen, L. Berger, M.J. Coady A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome N Engl J Med 362 12 2010 1102 1109
89. J. Marks, L.J. Churchill, S.K. Srai Intestinal phosphate absorption in a model of chronic renal failure Kidney Int 72 2007 166 173
90. M. Chonchol, R. Dale, R.W. Schrier, R. Estacio Serum phosphorus and cardiovascular mortality in type 2 diabetes Am J Med 122 4 2009 380 386
91. R.N. Foley, A.J. Collins, A. Ishani, P.A. Kalra Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 156 3 2008 556 563
92. S.J. Onufrak, A. Bellasi, F. Cardarelli Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality Am J Epidemiol 169 1 2009 67 77
93. S.J. Onufrak, A. Bellasi, L.J. Shaw Phosphorus levels are associated with subclinical atherosclerosis in the general population Atherosclerosis 199 2 2008 424 431
94. G. Saab, M.A. Whooley, N.B. Schiller, J.H. Ix Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study Am J Kidney Dis 56 3 2010 496 505
95. O.M. Gutierrez, R. Katz, C.A. Peralta Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA) J Ren Nutr 22 5 2012 480 489
96. M. Cirillo, C. Ciacci, N.G. De Santo Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults N Engl J Med 359 8 2008 864 866
97. J.H. Ix, M. Chonchol, G.A. Laughlin, M.G. Shlipak, M.A. Whooley Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study Am J Kidney Dis 58 5 2011 737 745
98. R.B. Oliveira, A.L. Cancela, F.G. Graciolli Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol 5 2 2010 286 291
99. T. Isakova, O.M. Gutierrez, K. Smith Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease Nephrol Dial Transplant 26 2 2011 584 591
100. E. Gonzalez-Parra, M.L. Gonzalez-Casaus, A. Galan Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients Nephrol Dial Transplant 26 8 2011 2567 2571
101. S.T. Chen, N.M. Maruthur, L.J. Appel The effect of dietary patterns on estimated coronary heart disease risk: results from the Dietary Approaches to Stop Hypertension (DASH) trial Circ Cardiovasc Qual Outcomes 3 5 2010 484 489
102. W. Jubiz, J.M. Canterbury, E. Reiss, F.H. Tyler Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels J Clin Invest 51 8 1972 2040 2046